donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > ALPMY ASTELLAS PHARMA > Key Indicators
ALPMY ASTELLAS PHARMA
16.000
-0.205-1.27%
YOY
Do not show
Hide blank lines
(FY)2022/03/31(Q4)2022/03/31(Q3)2021/12/31(Q2)2021/09/30
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
28.14% 146.6294 28.14% 146.6294 -0.39% 143.9053 32.39% 155.6844
Receivable Turnover(T)
-1.33% 3.5725 -1.33% 3.5725 2.8% 3.616 -1.67% 3.7238
Inventory Turnover(T)
2.16% 1.5955 2.16% 1.5955 3.17% 1.6427 -2.62% 1.6504
Fixed Assets Turnover(T)
3.65% 4.8576 3.65% 4.8576 2.43% 4.9749 -0.71% 4.8304
Total Asset Rate(T)
3.41% 0.5628 3.41% 0.5628 -4.37% 0.5592 -4.79% 0.5716
ROIC
2.52% 8.652% 2.52% 8.652% -16.85% 8.332% -19.76% 8.332%
ROE
-3.29% 8.719% -3.29% 8.719% -17.68% 8.478% -18.35% 8.689%
ROA
2.58% 5.388% 2.58% 5.388% -19.96% 5.165% -19.92% 5.307%
FCF to Sales
-23.94% 13.964% -23.94% 13.964% 4.23% 16.358% 67.05% 19.366%
FCF to Net Income
-23.32% 145.863% -23.32% 145.863% 24.53% 177.090% 98.61% 208.607%
Efficiency Ratios
ROE 5 Year Average
-11.86% 12.727% -- -- -- -- -- --
ROA 5 Year Average
-14.12% 8.140% -- -- -- -- -- --
Average 5 Years ROIC
-10.55% 12.452% -- -- -- -- -- --
Profitability Ratios TTM
Gross Margin
0.22% 80.480% 0.22% 80.480% -0.03% 80.597% 1% 80.458%
Operating Margin
-6.88% 10.104% -6.88% 10.104% -30.73% 9.151% -19.53% 10.756%
Net Margin
-0.8% 9.573% -0.8% 9.573% -16.3% 9.237% -15.89% 9.284%
EBITDA Margin
5.68% 0.1863% 5.68% 0.1863% -9.37% 0.1772% -10.79% 0.1736%
R & D Expense Ratio
5.62% 18.980% 5.62% 18.980% -3.71% 17.930% -1.15% 18.030%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
4.91% 42.340% 4.91% 42.340% 3.69% 42.100% 1.77% 41.430%
Financial Health Ratios
Total Assets to Common Equity
-2.63% 159.719% -2.63% 159.719% -4.25% 160.694% -5.18% 159.528%
Current Ratio
-8.81% 1.3432 -8.81% 1.3432 15.7% 1.5709 18.88% 1.5799
Quick Ratio
-8.09% 1.047 -8.09% 1.047 17.4% 1.2409 21.65% 1.2367
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
80.25% -0.261% -- -- -- -- -- --
Revenue CAGR(5Y)
87.25% -0.237% -- -- -- -- -- --
Net Income CAGR(3Y)
-78.99% -17.659% -- -- -- -- -- --
Net Income CAGR(5Y)
-18.51% -10.716% -- -- -- -- -- --
Dividend CAGR(3Y)
28.24% 7.883% -- -- -- -- -- --
Dividend CAGR(5Y)
61.1% 8.507% -- -- -- -- -- --
FCF 1 Year Growth
-135.65% -21.101% -- -- -- -- -- --
FCF CAGR(3Y)
22.64% -4.299% -- -- -- -- -- --
FCF CAGR(5Y)
-119.98% -0.647% -- -- -- -- -- --
Currency Unit
JPYJPYJPYJPY

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...